BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday, February 12, 2025. The firm expects ...

While value offerings are helping improve sales, some franchisees have yet to fully recover their visits and sales comps as ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...

In a report released yesterday, Gregory Lewis from BTIG maintained a Hold rating on Genco Shipping (GNK – Research Report). The company’s ...

BTIG Research has recently reduced MGM Resorts International (MGM) stock to Neutral rating, as announced on February 3, 2025, according to Finviz. Earlier, on July 3, 2024, BTIG Research had initiated ...

Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price target of $16.00. This upgrade comes after a ...

SailPoint, a leader in unified identity security for enterprises, today announced that it has launched the roadshow for its ...

BTIG analyst Mark Massaro announced an increased price target for IDEXX Laboratories (NASDAQ:IDXX), raising it from $500 to $530, while maintaining a Buy rating on the stock. The revision follows ...

Blank check company Rithm Acquisition, which is affiliated with Rithm Capital, filed for a $200 million initial public offering on Monday. The company said Michael Nierenberg, its chairman and chief ...

MicroStrategy (NASDAQ:MSTR – Get Free Report) is projected to announce its earnings results after the market closes on ...

Robeco Institutional Asset Management B.V. lowered its stake in shares of MGM Resorts International (NYSE:MGM – Free Report) ...

In terms of valuation, Akebia Therapeutics Inc’s market capitalization stands at $462.55 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...